Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | IDO1 | P14902 | 4/20 | 0.57 |
| ▸ | KCNJ1 | P48048 | 2/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19874575 | 0.98 | LOXL2 (0.67) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| Hydrochloric Acid SCHEMBL27576463 | 0.98 | LOXL2 (0.67) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| Hydrochloric Acid SCHEMBL115247 | 0.98 | LOXL2 (0.67) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| Bromide SCHEMBL11379599 | 0.98 | LOXL2 (0.67) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| Ammonia Solution, Strong SCHEMBL21518028 | 0.98 | LOXL2 (0.67) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| Hydrochloric Acid SCHEMBL1820969 | 0.96 | LOXL2 (0.64) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| SCHEMBL20303796 | 0.89 | HPGD (0.58) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| SCHEMBL43299 | 0.88 | LOXL2 (0.64) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| Sulfuric Acid SCHEMBL744265 | 0.88 | TSHR (0.56) | LOXL2TSHRALDH1A1IDO1KCNJ1 | |
| Pyridine SCHEMBL20534858 | 0.86 | POLB (0.56) | LOXL2TSHRALDH1A1IDO1KCNJ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 936 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121431735-B | Characterization method of molecular weight and molecular weight distribution of crystalline polyaryletherketone | 吉林大学 | 2026-05-19 | — | — | CN | claimed |
| CN-120040438-A | Isoxazole antiparasitic agents Synthesis method of medicine lotirana | 华南农业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119822969-A | Method for continuously preparing 4-nitrophenethylamine and salt thereof | 浙江华海药业股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119120606-A | Method for synthesizing (S) -1-tetrahydronaphthylamine by in-vitro multienzyme cascade catalysis | 华南理工大学 | 2024-12-13 | — | — | CN | claimed |
| US-20240350609-A1 | METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2024-10-24 | — | — | US | claimed |
| EP-4450082-A1 | METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF | Serum Institute Of India Private Limited (IN) | 2024-10-23 | — | — | EP | claimed |
| CN-118806889-A | Method for improving adsorption of polysaccharide-protein conjugates and multivalent vaccine formulations obtained therefrom | 印度血清研究所私人有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118290816-A | Recovery method of fiber-reinforced polyaryletherketone resin matrix composite material | 吉林大学 | 2024-07-05 | — | — | CN | claimed |
| CN-118147245-A | Biosynthesis method and system of salicylamine | 技源集团股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117886701-A | Full-continuous preparation method of 4-nitrophenethylamine | 爱斯特（成都）生物制药股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-6607725-B2 | Complex of lipooligosaccharide and immunology carriers | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2003-08-19 | — | — | US | claimed |
| US-6531131-B1 | Neisseria meningitidis lipooligosaccharide from which at least one primary O-linked fatty acid has been removed to detoxify it, covalently linked to immunogenic carrier | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2003-03-11 | — | — | US | claimed |
| US-20020001589-A1 | Conjugate vaccine for nontypeable haemophilus influenzae | GU XIN-XING (US) | 2002-01-03 | — | — | US | claimed |
| US-6207157-B1 | OLIGOSACCHARIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-03-27 | — | — | US | claimed |
| EP-1047447-A1 | LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF $i(MORAXELLA) $i((BRANHAMELLA)) $i(CATARRHALIS) INFECTIONS IN MAMMALS | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-11-02 | — | — | EP | claimed |
| WO-1999036086-A1 | LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARRHALIS INFECTIONS IN MAMMALS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-07-22 | — | — | WO | claimed |
| WO-1998026799-A1 | CONJUGATE VACCINE FOR SALMONELLA PARATYPHI A | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-06-25 | — | — | WO | claimed |
| US-5756507-A | TREATING SEX HORMONE RELATED DISORDERS | MERCK & CO., INC. (US) | 1998-05-26 | — | — | US | claimed |
| EP-0385658-B1 | Ring-substituted 2-amino 1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes | LILLY CO ELI (US) | 1994-12-28 | — | — | EP | claimed |
| EP-0385658-A1 | Ring-substituted 2-amino 1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes | ELI LILLY AND COMPANY (US) | 1990-09-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240350609-A1 | METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF | DDOST, CD14, STT3B | LOXL2 4696/4885TSHR 3128/4885ALDH1A1 4882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.